These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21299520)

  • 1. Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LCH, Chin RKH Aust N Z J Obstet Gynaecol 2010; 50 (3): 273-279.
    Basu A; Haran M; Nair A
    Aust N Z J Obstet Gynaecol; 2011 Feb; 51(1):97-8. PubMed ID: 21299520
    [No Abstract]   [Full Text] [Related]  

  • 2. Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial.
    Wong AY; Tang LC; Chin RK
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):273-9. PubMed ID: 20618247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
    Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
    Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment.
    Engemise SL; Willets JM; Emembolu JO; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):439-42. PubMed ID: 22018831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena) and depot-medroxyprogesterone acetate (Depo-Provera) on subendometrial microvascularisation and uterine artery blood flow.
    Dane B; Akca A; Dane C; Evcimen S; Cetin A
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):240-4. PubMed ID: 19565422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Dennerstein letter: Bowel resection for severe endometriosis: an Australian series of 177 cases.
    Cooper M; Reid G; Tsaltas J
    Aust N Z J Obstet Gynaecol; 2011 Feb; 51(1):96. PubMed ID: 21299519
    [No Abstract]   [Full Text] [Related]  

  • 7. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up.
    Howard DL; Wayman R; Strickland JL
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):358-65. PubMed ID: 24238267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.
    Petta CA; Ferriani RA; Abrão MS; Hassan D; Rosa e Silva JC; Podgaec S; Bahamondes L
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):128-9. PubMed ID: 19181433
    [No Abstract]   [Full Text] [Related]  

  • 9. Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception.
    Guirguis-Blake J
    Am Fam Physician; 2011 Jan; 83(1):35-6. PubMed ID: 21888124
    [No Abstract]   [Full Text] [Related]  

  • 10. Depot medroxyprogesterone acetate (Depo-Provera) and levonorgestrel (Norplant) use in adolescents among clinicians in Northern Europe and the United States.
    Cromer BA; Berg-Kelly KS; Van Groningen JP; Seimer BS; Ruusuvaara L
    J Adolesc Health; 1998 Aug; 23(2):74-80. PubMed ID: 9714169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
    Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
    Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two for the price of one.
    Samuel MI; Tenant-Flowers M; Kumar U; Taylor C
    Int J STD AIDS; 2008 Oct; 19(10):719-20. PubMed ID: 18824630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bowel resection for severe endometriosis: an Australian series of 177 cases.
    Dennerstein GJ; Fernando S
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):306. PubMed ID: 20618257
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel.
    Lockhat FB; Emembolu JE; Konje JC
    Fertil Steril; 2005 Feb; 83(2):398-404. PubMed ID: 15705381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system--Mirena.
    Skrzypulec V; Drosdzol A
    Coll Antropol; 2008 Dec; 32(4):1059-68. PubMed ID: 19149209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating endometriosis with the levonorgestrel-releasing intrauterine system: real hope or gimmick?
    Ibraheim M; Ikomi A
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):182-4. PubMed ID: 16105274
    [No Abstract]   [Full Text] [Related]  

  • 19. Interval of injections of intramuscular depot medroxyprogesterone acetate in the long-term treatment of endometriosis-associated pain: a randomized comparative trial.
    Cheewadhanaraks S; Peeyananjarassri K; Choksuchat C; Dhanaworavibul K; Choobun T; Bunyapipat S
    Gynecol Obstet Invest; 2009; 68(2):116-21. PubMed ID: 19556801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for the use of progestin-only contraceptives.
    Freeman S; Shulman LP
    J Am Acad Nurse Pract; 2010 Feb; 22(2):81-91. PubMed ID: 20132366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.